Yamaguchi O, Marui E, Kakizaki H, Itoh N, Yokota T, Okada H, Ishizuka O, Ozono S, Yoshida M, On behalf of the Japanese Solifenacin Study Group: Randomized, double-blind, placebo-and porpiverine-controlled trial of the once-daily antimuscaric agent solifenacin in Japanese patients with overactive bladder BJU, INT, 100(3)579-587, 2007